59 related articles for article (PubMed ID: 23582651)
1. Is alpha-B crystallin an independent marker for prognosis in lung cancer?
Campbell-Lloyd AJ; Mundy J; Deva R; Lampe G; Hawley C; Boyle G; Griffin R; Thompson C; Shah P
Heart Lung Circ; 2013 Sep; 22(9):759-66. PubMed ID: 23582651
[TBL] [Abstract][Full Text] [Related]
2. Alpha B-crystallin - a validated prognostic factor for poor prognosis in squamous cell carcinoma of the oral cavity.
Annertz K; Enoksson J; Williams R; Jacobsson H; Coman WB; Wennerberg J
Acta Otolaryngol; 2014 May; 134(5):543-50. PubMed ID: 24702231
[TBL] [Abstract][Full Text] [Related]
3. Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.
Leinonen T; Pirinen R; Böhm J; Johansson R; Rinne A; Weber E; Kosma VM
J Clin Pathol; 2007 May; 60(5):515-9. PubMed ID: 16790691
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of the small heat-shock protein alpha-B-crystallin in operated-on non-small-cell lung cancer patients: clinical implication.
Cherneva R; Petrov D; Georgiev O; Slavova Y; Toncheva D; Stamenova M; Trifonova N
Eur J Cardiothorac Surg; 2010 Jan; 37(1):44-50. PubMed ID: 19651521
[TBL] [Abstract][Full Text] [Related]
6. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
7. Distribution of Bcl-2 gene expression and its prognostic value in non-small cell lung cancer.
Yilmaz A; Savaş I; Dizbay Sak S; Güngör A; Kaya A; Serinsöz E; Savaş B
Tuberk Toraks; 2005; 53(4):323-9. PubMed ID: 16456730
[TBL] [Abstract][Full Text] [Related]
8. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
10. Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer.
Chin D; Boyle GM; Williams RM; Ferguson K; Pandeya N; Pedley J; Campbell CM; Theile DR; Parsons PG; Coman WB
Laryngoscope; 2005 Jul; 115(7):1239-42. PubMed ID: 15995513
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CD151 overexpression in non-small cell lung cancer.
Kwon MJ; Seo J; Kim YJ; Kwon MJ; Choi JY; Kim TE; Lee DH; Park S; Shin YK; Han J; Choi YL
Lung Cancer; 2013 Jul; 81(1):109-16. PubMed ID: 23570797
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
13. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
[TBL] [Abstract][Full Text] [Related]
15. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
[TBL] [Abstract][Full Text] [Related]
16. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.
Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ
Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer.
Ko E; Kim Y; Cho EY; Han J; Shim YM; Park J; Kim DH
Ann Surg Oncol; 2013 Mar; 20(3):1005-12. PubMed ID: 23115005
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the prognostic impact of nestin expression in non-small cell lung cancer.
Skarda J; Kolar Z; Janikova M; Radova L; Kolek V; Fridman E; Kopolovic J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):135-42. PubMed ID: 22837134
[TBL] [Abstract][Full Text] [Related]
19. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
[TBL] [Abstract][Full Text] [Related]
20. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
Anton RC; Coffey DM; Gondo MM; Stephenson MA; Brown RW; Cagle PT
Mod Pathol; 2000 Nov; 13(11):1167-72. PubMed ID: 11106072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
